Toll Free: 1-888-928-9744
Published: Aug, 2016 | Pages:
122 | Publisher: QYResearch
Industry: Pharmaceutical | Report Format: Electronic (PDF)
This report studies sales (consumption) of Regenerative Medicines in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering Celgene Corporation (U.S.) StemCells, Inc. (U.S.) Corning Incorporated (U.S.) Organogenesis Inc. (U.S.) Acelity (KCI Licensing) (U.S.) Vertex Pharmaceuticals Incorporated (U.S.) Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into Cell Therapy Gene Therapy Immunotherapy Tissue Engineering Split by applications, this report focuses on sales, market share and growth rate of Regenerative Medicines in each application, can be divided into Department of orthopedics and musculoskeletal spine Skin disease Cardiovascular Central nervous system Oncology Diabetes
Table of Contents
United States Regenerative Medicines Sales Market Report 2021 1 Regenerative Medicines Overview 1.1 Product Overview and Scope of Regenerative Medicines 1.2 Classification of Regenerative Medicines 1.2.1 Cell Therapy 1.2.2 Gene Therapy 1.2.3 Immunotherapy 1.2.4 Tissue Engineering 1.3 Applications of Regenerative Medicines 1.3.1 Department of orthopedics and musculoskeletal spine 1.3.2 Skin disease 1.3.3 Cardiovascular 1.3.4 Central nervous system 1.3.5 Oncology 1.3.6 Diabetes 1.4 USA Market Size (Value and Volume) of Regenerative Medicines (2011-2021) 1.4.1 USA Regenerative Medicines Sales, Revenue and Price (2011-2021) 1.4.2 USA Regenerative Medicines Sales and Growth Rate (2011-2021) 1.4.3 USA Regenerative Medicines Revenue and Growth Rate (2011-2021) 2 USA Regenerative Medicines Competition by Manufacturers 2.1 USA Regenerative Medicines Sales and Market Share of Key Manufacturers (2015 and 2016) 2.2 USA Regenerative Medicines Revenue and Share by Manufactures (2015 and 2016) 3 USA Regenerative Medicines (Volume and Value) by Type 3.1 USA Regenerative Medicines Sales and Market Share by Type (2011-2021) 3.2 USA Regenerative Medicines Revenue and Market Share by Type (2011-2021) 4 USA Regenerative Medicines (Volume) by Application 5 USA Regenerative Medicines Manufacturers Analysis 5.1 Celgene Corporation (U.S.) 5.1.1 Company Basic Information, Manufacturing Base and Competitors 5.1.2 Regenerative Medicines Product Type and Technology 5.1.2.1 Cell Therapy 5.1.2.2 Gene Therapy 5.1.3 Regenerative Medicines Sales, Revenue, Price of Celgene Corporation (U.S.) (2015 and 2016) 5.2 StemCells, Inc. (U.S.) 5.2.1 Company Basic Information,Manufacturing Base and Competitors 5.2.2 Pharmaceuticals Product Type and Technology 5.2.2.1 Cell Therapy 5.2.2.2 Gene Therapy 5.2.3 Pharmaceuticals Sales, Revenue, Price of StemCells, Inc. (U.S.) (2015 and 2016) 5.3 Corning Incorporated (U.S.) 5.3.1 Company Basic Information,Manufacturing Base and Competitors 5.3.2 Corning Incorporated (U.S.) Product Type and Technology 5.3.2.1 Cell Therapy 5.3.2.2 Gene Therapy 5.3.3 Corning Incorporated (U.S.) Sales, Revenue, Price of Corning Incorporated (U.S.) (2015 and 2016) 5.4 Organogenesis Inc. (U.S.) 5.4.1 Company Basic Information,Manufacturing Base and Competitors 5.4.2 Product Type and Technology 5.4.2.1 Cell Therapy 5.4.2.2 Gene Therapy 5.4.3 Organogenesis Inc. (U.S.) Sales, Revenue, Price of Organogenesis Inc. (U.S.) (2015 and 2016) 5.5 Acelity (KCI Licensing) (U.S.) 5.5.1 Company Basic Information,Manufacturing Base and Competitors 5.5.2 Acelity (KCI Licensing) (U.S.) Product Type and Technology 5.5.2.1 Cell Therapy 5.5.2.2 Gene Therapy 5.5.3 Acelity (KCI Licensing) (U.S.) Sales, Revenue, Price of Acelity (KCI Licensing) (U.S.) (2015 and 2016) 5.6 Vertex Pharmaceuticals Incorporated (U.S.) 5.6.1 Company Basic Information,Manufacturing Base and Competitors 5.6.2 Vertex Pharmaceuticals Incorporated (U.S.) Product Type and Technology 5.6.2.1 Cell Therapy 5.6.2.2 Gene Therapy 5.6.3 Vertex Pharmaceuticals Incorporated (U.S.) Sales, Revenue, Price of Vertex Pharmaceuticals Incorporated (U.S.) (2015 and 2016) 6 Regenerative Medicines Technology and Development Trend 6.1 Regenerative Medicines Technology Analysis 6.2 Regenerative Medicines Technology Development Trend 7 Research Findings and Conclusion
List of Tables and Figure
Figure Picture of Regenerative Medicines Table Classification of Regenerative Medicines Figure USA Sales Market Share of Regenerative Medicines by Type in 2015 Figure Cell Therapy Picture Figure Gene Therapy Picture Figure Immunotherapy Picture Figure Tissue Engineering Picture Table Applications of Regenerative Medicines Figure USA Sales Market Share of Regenerative Medicines by Application in 2015 Figure Department of orthopedics and musculoskeletal spine Examples Figure Skin disease Examples Figure Cardiovascular Examples Figure Central nervous system Examples Figure Oncology Examples Figure Diabetes Examples Table USA Regenerative Medicines Sales, Revenue and Price (2011-2021) Figure USA Regenerative Medicines Sales and Growth Rate (2011-2021) Figure USA Regenerative Medicines Revenue and Growth Rate (2011-2021) Table USA Regenerative Medicines Sales of Key Manufacturers (2015 and 2016) Table USA Regenerative Medicines Sales Share by Manufacturers (2015 and 2016) Figure 2015 Regenerative Medicines Sales Share by Manufacturers Figure 2016 Regenerative Medicines Sales Share by Manufacturers Table USA Regenerative Medicines Revenue by Manufacturers (2015 and 2016) Table USA Regenerative Medicines Revenue Share by Manufacturers (2015 and 2016) Table 2015 USA Regenerative Medicines Revenue Share by Manufacturers Table 2016 USA Regenerative Medicines Revenue Share by Manufacturers Table USA Regenerative Medicines Sales and Market Share by Type (2011-2021) Table USA Regenerative Medicines Sales Share by Type (2011-2021) Figure Sales Market Share of Regenerative Medicines by Type (2011-2021) Figure USA Regenerative Medicines Sales Growth Rate by Type (2011-2021) Table USA Regenerative Medicines Revenue and Market Share by Type (2011-2021) Table USA Regenerative Medicines Revenue Share by Type (2011-2021) Figure Revenue Market Share of Regenerative Medicines by Type (2011-2021) Figure USA Regenerative Medicines Revenue Growth Rate by Type (2011-2021) Table USA Regenerative Medicines Sales and Market Share by Application (2011-2021) Table USA Regenerative Medicines Sales Share by Application (2011-2021) Figure Sales Market Share of Regenerative Medicines by Application (2011-2021) Figure USA Regenerative Medicines Sales Growth Rate by Application (2011-2021) Table Celgene Corporation (U.S.) Basic Information List Table Regenerative Medicines Sales, Revenue, Price of Celgene Corporation (U.S.) (2015 and 2016) Table StemCells, Inc. (U.S.) Basic Information List Table Regenerative Medicines Sales, Revenue, Price of StemCells, Inc. (U.S.) (2015 and 2016) Table Corning Incorporated (U.S.) Basic Information List Table Regenerative Medicines Sales, Revenue, Price of Corning Incorporated (U.S.) (2015 and 2016) Table Organogenesis Inc. (U.S.) Basic Information List Table Regenerative Medicines Sales, Revenue, Price of Organogenesis Inc. (U.S.) (2015 and 2016) Table Acelity (KCI Licensing) (U.S.) Basic Information List Table Regenerative Medicines Sales, Revenue, Price of Acelity (KCI Licensing) (U.S.) (2015 and 2016) Table Vertex Pharmaceuticals Incorporated (U.S.) Basic Information List Table Regenerative Medicines Sales, Revenue, Price of Vertex Pharmaceuticals Incorporated (U.S.) (2015 and 2016)
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.